FDA plans to phase out phenylephrine in cold medicines due to its ineffectiveness.

The FDA plans to phase out phenylephrine, a decongestant in popular cold medicines like Sudafed and Dayquil, due to its ineffectiveness in relieving nasal congestion. This decision follows studies showing phenylephrine is no better than a placebo. Drug manufacturers may need to remove or reformulate products. Doctors recommend alternatives such as saline rinses, nasal steroids like Flonase, and antihistamine sprays for relief.

3 months ago
84 Articles